Pricing Log in Create free account

Haemonetics Corporation (HAE) vs LivaNova PLC (LIVN)

Haemonetics Corporation and LivaNova PLC are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $5.7B against $5.0B — 1.1× the size. LivaNova PLC trades at the lower P/E: 25.6× against 54.5×. LivaNova PLC grew revenue faster over the last twelve months: 11.7% against 4.11%. LivaNova PLC has the higher net margin (13.0% vs 7.52%) and the higher return on invested capital (9.14% vs 6.31%). Across the 22 metrics below, LivaNova PLC leads on 14 and Haemonetics Corporation on 8.

Valuation

Metric HAE LIVN Medical Devices median
P/E 54.48 25.58 25.58
P/S 4.05 3.35 2.54
P/B 6.24 3.81 2.48
Price to free cash flow 18.11 37.98 28.81
EV/EBITDA 23.58 17.56 11.51
EV/Sales 4.67 3.18 2.72
Earnings yield 1.84% 3.91% (12.82%)
Free cash flow yield 5.52% 2.63% (8.18%)

Profitability

Metric HAE LIVN Medical Devices median
Gross margin 59.63% 67.84% 57.76%
Operating margin 12.80% 10.75% (15.07%)
Net margin 7.52% 13.01% (14.45%)
Free cash flow margin 24.95% 9.05% (3.88%)
Return on equity 11.89% 15.50% (10.35%)
Return on assets 4.28% 7.44% (17.26%)
Return on invested capital 6.31% 9.14% (5.27%)

Growth

Metric HAE LIVN Medical Devices median
Revenue growth (TTM) 4.11% 11.71% 10.41%
EPS growth (last fiscal year) (38.07%) (483.62%) 28.17%
Revenue growth, 5-year CAGR 8.91% 8.24% 15.74%
Net income growth, 5-year CAGR 4.13% 0.00% 0.00%

Health

Metric HAE LIVN Medical Devices median
Debt to equity 1.24 0.22 0.04
Current ratio 2.84 1.74 2.74
Net debt to EBITDA 3.55 (0.92) 0.54

Dividend

Metric HAE LIVN Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric HAE LIVN Medical Devices median
Market cap 5.65b 5.02b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack